Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · enVVeno Medical Corp (NVNO)

enVVeno Medical files investor presentation under Regulation FD on July 14, 2026

Neutral Impact 1 of 5 other Written later

enVVeno Medical Corporation issued an investor presentation on July 14, 2026, which it may use with investors, analysts and others. The filing states the presentation is attached as Exhibit 99.1 but does not summarize its contents, so the filing itself reports no new financial results, guidance or deal terms.

Key points

  • Investor presentation issued July 14, 2026, attached as Exhibit 99.1
  • Company may use the presentation at investor, analyst and other meetings, in whole or in part
  • Filing contains no financial figures, guidance or transaction terms in its text
  • Signed by CEO Robert A. Berman

The filing

CompanyenVVeno Medical Corp (NVNO)
Form8-K, current report
Filed with the SECJul 14, 2026, 4:55 PM ET
Accession number0001493152-26-033193

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:53 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 14, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.